Non-Current Assets

Long- term Investments

Regeneron Pharmaceuticals Long- term Investments decreased by 4.6% to $9.79B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.5%, from $9.28B to $9.79B. Over 5 years (FY 2020 to FY 2025), Long- term Investments shows an upward trend with a 26.8% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: non_current_assets_marketable_securities_noncurrent

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$3.90B$5.63B$6.84B$7.08B$6.42B$5.97B$6.59B$6.07B$6.33B$5.78B$5.40B$6.98B$7.72B$8.49B$8.90B$9.28B$10.06B$10.29B$10.26B$9.79B
QoQ Change—+44.4%+21.4%+3.6%-9.4%-7.0%+10.4%-8.0%+4.3%-8.7%-6.6%+29.3%+10.7%+10.0%+4.8%+4.2%+8.4%+2.3%-0.2%-4.6%
YoY Change————+64.5%+6.0%-3.6%-14.4%-1.4%-3.2%-18.1%+15.0%+22.1%+46.9%+64.9%+32.9%+30.2%+21.1%+15.3%+5.5%
Range$3.90B – $10.29B
CAGR+21.4%
Avg YoY Growth+17.7%
Median YoY Growth+15.2%
Current Streak2 quarters decline

Frequently Asked Questions

What is Regeneron Pharmaceuticals's long- term investments?
Regeneron Pharmaceuticals (REGN) reported long- term investments of $9.79B in Q1 2026.
How has Regeneron Pharmaceuticals's long- term investments changed year-over-year?
Regeneron Pharmaceuticals's long- term investments increased by 5.5% year-over-year, from $9.28B to $9.79B.
What is the long-term trend for Regeneron Pharmaceuticals's long- term investments?
Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's long- term investments has grown at a 26.8% compound annual growth rate (CAGR), from $3.14B to $10.26B.